Charles River Laboratories International (CRL) Gains from Investment Securities (2009 - 2025)

Charles River Laboratories International's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $802000.0 for Q4 2025.

• In Q4 2025, Gains from Investment Securities rose 116.34% year-over-year to $802000.0; the TTM figure through Dec 2025 stood at -$2.5 million (up 44.95% YoY), while the FY2025 annual figure was -$2.5 million, up 44.95% from the prior year.
• Gains from Investment Securities was $802000.0 for Q4 2025 at Charles River Laboratories International, up from -$3.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $15.5 million in Q4 2022 to a low of -$36.3 million in Q3 2022.
• Historically, Gains from Investment Securities has averaged -$1.4 million across 5 years, with a median of $110000.0 in 2022.
• Biggest YoY gain for Gains from Investment Securities was 2227.71% in 2022; the steepest drop was 3816.81% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at $664000.0 in 2021, then soared by 2227.71% to $15.5 million in 2022, then sank by 120.21% to -$3.1 million in 2023, then sank by 57.12% to -$4.9 million in 2024, then jumped by 116.34% to $802000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $802000.0 (Q4 2025), -$3.0 million (Q3 2025), and -$243000.0 (Q2 2025), per Business Quant data.